News

Injective Launches TradFi Stock Index, Bringing Traditional Equities On-Chain

by Soumen Datta

February 11, 2025

chain

The product offers 24/7 market access, up to 25X leverage, and permissionless trading, eliminating the inefficiencies of traditional stock markets.

Injective introduced the TradFi Stock Index, an on-chain index tracking hundreds of major publicly traded companies, including Amazon, Apple, Microsoft, and Goldman Sachs.

This marks a significant milestone in bringing legacy finance into the blockchain space while enabling global, permissionless access to equity markets.

The TradFi Stock Index is available on Helix, Injective’s decentralized exchange (DEX). Unlike traditional markets with limited trading hours, this on-chain index allows users to trade stocks 24/7 with up to 25X leverage.

Key Features of the TradFi Stock Index

According to the Injective team, Injective’s latest index aims to break down barriers in equity trading by offering several key advantages:

1. 24/7 Trading

Traditional stock markets operate within set hours, limiting access for global investors. The TradFi index on Helix eliminates this constraint, allowing users to trade equities anytime, anywhere.

2. High Leverage

The market allows traders to use up to 25X leverage, enabling sophisticated trading strategies that are usually available only in high-end financial institutions. Investors can take long or short positions to manage risk.

3. Permissionless Access

Unlike conventional stock markets that require brokerage accounts and regulatory compliance, Injective’s index is fully decentralized. Users can trade without intermediaries, making stock market exposure accessible to a global audience.

4. Hedging and Diversification

Traders can take long or short positions on the broader U.S. stock market, providing new hedging opportunities. The index gives exposure to multiple blue-chip stocks, helping users diversify risk in a decentralized setting.

“By bringing the most sought-after traditional finance markets on-chain, we’re not just creating a new trading product; we’re redefining what’s possible in decentralized finance,” Eric Chen, CEO and co-founder of Injective Labs.

Injective’s goal is to tokenize all financial assets, making them tradable on-chain without restrictions. This vision aligns with the growing trend of DeFi disrupting legacy financial systems.

This move follows Injective’s recent launch of the AI Index Perpetual Market (AIX), which combines AI-related equities and crypto assets. 

Additionally, Korea Digital Asset Custody (KDAC), a major institutional custodian, has joined Injective’s network as a validator. This partnership strengthens Injective’s security and opens doors to institutional investors in Asia.

Disclaimer

Disclaimer: The views expressed in this article do not necessarily represent the views of BSCN. The information provided in this article is for educational and entertainment purposes only and should not be construed as investment advice, or advice of any kind. BSCN assumes no responsibility for any investment decisions made based on the information provided in this article. If you believe that the article should be amended, please reach out to the BSCN team by emailing [email protected].

Author

Soumen Datta

Soumen is an experienced writer in cryptocurrencies, DeFi, NFTs, and GameFi. He has been analyzing the space for the last several years and believes there is a lot of potential with blockchain technology, even though we are still at an early stage. In his spare time, Soumen enjoys playing his guitar and singing along. Soumen holds bags in BTC, ETH, BNB, MATIC, and ADA.

;